No Image
Polyclonal Antibodies
Anti-FAH Polyclonal Antibody for WB, IF/ICC, ELISA - P16930
Item Number : CM0025477
Price varies based on specs and customizations
- Application
- WB, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 46kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | FAH Rabbit pAb |
| Remarks/Alias | FAH |
| Species | Human |
| Gene ID | 2184 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-419 of human FAH (NP_000128.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P16930 |
| Protein Weight | 46kDa |
| Shipping | Ice bag |
Biological Background: FAH Function and Localization
- Fumarylacetoacetase (FAH), also known as beta-diketonase or fumarylacetoacetate hydrolase, is encoded by the FAH gene in humans. Alternative splicing generates multiple isoforms.
- As indicated by its annotation, FAH functions as a hydrolase in the final step of phenylalanine and tyrosine catabolism, catalyzing the hydrolysis of fumarylacetoacetate to fumarate and acetoacetate.
- The enzyme requires divalent metal ions, specifically magnesium and calcium, for its catalytic activity.
- Post-translational modifications of FAH include acetylation and phosphorylation, identified through direct protein sequencing and proteomics analyses.
- FAH is predominantly expressed in liver and kidney, with lower detection in various other tissues.
- Disease-associated variants of FAH are linked to metabolic disorders, particularly tyrosinemia type I.
Experimental Guidance and Technical Tips
- The immunogen corresponds to full-length human FAH, potentially allowing recognition of multiple isoforms; verify specificity in your experimental system.
- For Western blot, the expected protein weight is ~46 kDa; validate the detected band using appropriate positive controls (e.g., liver or kidney lysates) and consider blocking conditions to reduce non-specific binding.
- In immunofluorescence (IF/ICC), test various fixation and permeabilization methods to achieve optimal nuclear/cytoplasmic staining based on the expected subcellular distribution of FAH.
- For ELISA, the antibody pair compatibility should be determined empirically; optimize coating concentration and detection conditions for best signal-to-noise ratio.
- Since the antibody shows cross-reactivity with mouse and rat, it may be suitable for comparative studies across species; confirm reactivity in the relevant model organism.
- Always include appropriate positive and negative controls to ensure assay performance.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio serves as a comprehensive sourcing partner for diagnostic manufacturers and research laboratories, offering this anti-FAH polyclonal antibody alongside validated antibody pairs, bulk ancillary reagents, and custom raw-material solutions. With a focus on metabolic disorder research areas, we help streamline your procurement from discovery to clinical application.
Product Datasheet
Anti-FAH Polyclonal Antibody for WB, IF/ICC, ELISA - P16930
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!